CD8A and neoplasm: However, when CD8+ TIL infiltrate was combined with HLA class 1 status, it became clear that higher pCR rates and a better DFS were detected in patients with a strongly CD8+ T-cell infiltrated tumor which had retained a strong expression of HLA class 1.